tiprankstipranks
Baudax Bio (BXRX)
OTHER OTC:BXRX
US Market

Baudax Bio (BXRX) Financial Statements

760 Followers

Baudax Bio Financial Overview

Baudax Bio's market cap is currently ―. The company's EPS TTM is $-9.164; its P/E ratio is >-0.01; Baudax Bio is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 30.00K$ 14.00K$ 309.00K$ 238.00K$ 300.00K
Gross Profit$ -74.00K$ 419.00K$ -4.98M$ -970.00K$ -61.00K
EBIT$ -7.30M$ -7.39M$ -8.60M$ -6.07M$ -5.65M
EBITDA$ -7.30M$ -7.38M$ -8.54M$ -5.38M$ -4.96M
Net Income Common Stockholders$ -7.30M$ -7.39M$ -9.25M$ -29.20M$ -7.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.42M$ 3.80M$ 5.26M$ 5.65M$ 5.21M
Total Assets$ 21.32M$ 7.07M$ 10.03M$ 17.51M$ 40.83M
Total Debt$ 8.77M$ 7.43M$ 7.12M$ 8.09M$ 8.71M
Net Debt$ 7.36M$ 3.63M$ 1.86M$ 2.44M$ 3.50M
Total Liabilities$ 32.00M$ 14.38M$ 34.27M$ 37.05M$ 36.60M
Stockholders Equity$ -10.68M$ -7.31M$ -24.24M$ -19.54M$ 4.23M
Cash Flow-
Free Cash Flow$ -3.64M$ -4.66M$ -3.78M$ -3.89M$ -7.22M
Operating Cash Flow$ -3.64M$ -4.66M$ -3.78M$ -3.89M$ -7.22M
Investing Cash Flow$ 333.00K--$ 0.00$ 0.00
Financing Cash Flow$ 917.00K$ 3.21M$ 3.40M$ 4.33M$ 902.00K
Currency in USD

Baudax Bio Earnings and Revenue History

Baudax Bio Debt to Assets

Baudax Bio Cash Flow

Baudax Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis